Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...

Oblíbené léky na hubnutí, jako jsou Ozempic nebo Wegovy, mohou podle nové americké studie snižovat riziko demence, ...

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

A new study reveals key predictors of successful weight loss on GLP-1RA drugs like Ozempic and Wegovy, including longer ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Most of the scariest side effects of weight-loss drugs like Ozempic, Wegovy, and Zepbound have been gastrointestinal.

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

Wegovy, a weight loss drug, is gaining popularity for its effectiveness, but experts emphasize that it's most successful when ...

Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...